adult-onset Still’s disease

Some concerns from Turkey
Emre Bilgin, İrem Ozarli, Levent Kılıç, Ertuğrul Çağrı Bölek, Gözde Kübra Yardımcı, Ömer Karadağ

Annals of the Rheumatic Diseases Feb 2020, 79 (2) e15; DOI: 10.1136/annrheumdis-2018-214739
Tocilizumab in patients with adult-onset still’s disease refractory to glucocorticoid treatment: a randomised, double-blind, placebo-controlled phase III trial
Yuko Kaneko, Hideto Kameda, Kei Ikeda, Tomonoti Ishii, Kosaku Murakami, Hyota Takamatsu, Yoshiya Tanaka, Takayuki Abe, Tsutomu Takeuchi

Annals of the Rheumatic Diseases Dec 2018, 77 (12) 1720-1729; DOI: 10.1136/annrheumdis-2018-213920
Response to: ‘Is the PET/CT first choice for differential diagnosis of FUO/IUO?’ by Armagan et al
Verena Schönau, Georg Schett

Annals of the Rheumatic Diseases Nov 2018, 77 (11) e83; DOI: 10.1136/annrheumdis-2017-212785

Main menu